BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34747958)

  • 1. Natural compounds from
    Platella C; Capasso D; Riccardi C; Musumeci D; DellaGreca M; Montesarchio D
    Org Biomol Chem; 2021 Nov; 19(45):9953-9965. PubMed ID: 34747958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Targeting of Cancer-Related G-Quadruplex Structures by the Natural Compound Dicentrine.
    Platella C; Ghirga F; Musumeci D; Quaglio D; Zizza P; Iachettini S; D'Angelo C; Biroccio A; Botta B; Mori M; Montesarchio D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives.
    Platella C; Criscuolo A; Riccardi C; Gaglione R; Arciello A; Musumeci D; DellaGreca M; Montesarchio D
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the binding of naphthalene diimides to a human telomeric G-quadruplex multimer model.
    Pirota V; Platella C; Musumeci D; Benassi A; Amato J; Pagano B; Colombo G; Freccero M; Doria F; Montesarchio D
    Int J Biol Macromol; 2021 Jan; 166():1320-1334. PubMed ID: 33166559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral metallo-supramolecular complexes selectively recognize human telomeric G-quadruplex DNA.
    Yu H; Wang X; Fu M; Ren J; Qu X
    Nucleic Acids Res; 2008 Oct; 36(17):5695-703. PubMed ID: 18776218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 2,9-disubstituted-1,10-phenanthroline derivatives with anticancer activity by selective targeting of telomeric G-quadruplex DNA.
    Craciun AM; Rotaru A; Cojocaru C; Mangalagiu II; Danac R
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119318. PubMed ID: 33360205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
    Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifunctionalized Naphthalene Diimides and Dimeric Analogues as G-Quadruplex-Targeting Anticancer Agents Selected by Affinity Chromatography.
    Platella C; Pirota V; Musumeci D; Rizzi F; Iachettini S; Zizza P; Biroccio A; Freccero M; Montesarchio D; Doria F
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis of 4,5-diazafluorene derivatives and their anticancer activity via targeting telomeric DNA G-quadruplex.
    Zhou K; Liu J; Xiong X; Cheng M; Hu X; Narva S; Zhao X; Wu Y; Zhang W
    Eur J Med Chem; 2019 Sep; 178():484-499. PubMed ID: 31202994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.
    Cosconati S; Rizzo A; Trotta R; Pagano B; Iachettini S; De Tito S; Lauri I; Fotticchia I; Giustiniano M; Marinelli L; Giancola C; Novellino E; Biroccio A; Randazzo A
    J Med Chem; 2012 Nov; 55(22):9785-92. PubMed ID: 23057850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential Recognition of Human Telomeric G-Quadruplex DNA by a Red-Emissive Molecular Rotor.
    Verma S; Patidar RK; Tiwari K; Tiwari R; Baranwal J; Velayutham R; Ranjan N
    J Phys Chem B; 2022 Sep; 126(38):7298-7309. PubMed ID: 36103341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties.
    Renuga D; Maheswari PU; Begum KMMS; Prabaharan D
    Anticancer Agents Med Chem; 2021; 21(17):2407-2418. PubMed ID: 33463477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterocyclic dications as a new class of telomeric G-quadruplex targeting agents.
    Nanjunda R; Musetti C; Kumar A; Ismail MA; Farahat AA; Wang S; Sissi C; Palumbo M; Boykin DW; Wilson WD
    Curr Pharm Des; 2012; 18(14):1934-47. PubMed ID: 22380518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]
    Raje S; Pandav K; Barthwal R
    Bioorg Med Chem; 2019 Dec; 27(24):115131. PubMed ID: 31685331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA.
    Castillo-González D; Pérez-Machado G; Guédin A; Mergny JL; Cabrera-Pérez MA
    Curr Pharm Des; 2013; 19(12):2164-73. PubMed ID: 23016840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands.
    Kaulage MH; Maji B; Pasadi S; Ali A; Bhattacharya S; Muniyappa K
    Eur J Med Chem; 2018 Mar; 148():178-194. PubMed ID: 29459277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
    Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.